| Price | 6.55p on 24-06-2026 at 07:00:40 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.70p |
| Sell | 6.40p |
| Last Trade: | Sell 50,000.00 at 6.415p |
| Day's Volume: | 0 |
| Last Close: | 6.55p |
| Open: | 6.55p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.55p - 6.55p |
| 52wk Range: | 2.60p - 12.35p |
| Market Capitalisation: | £70.05m |
| VWAP: | 0.00p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 50,000 | 6.415p | Ordinary |
16:22:49 - 23-Jun-26 |
| Sell* | 25,000 | 6.415p | Ordinary |
16:19:55 - 23-Jun-26 |
| Sell* | 150,000 | 6.40p | Ordinary |
16:16:17 - 23-Jun-26 |
| Sell* | 16,252 | 6.415p | Ordinary |
14:43:35 - 23-Jun-26 |
| Sell* | 11,361 | 6.54p | Ordinary |
13:58:29 - 23-Jun-26 |
| Buy* | 2,000 | 6.70p | SI Trade |
13:57:55 - 23-Jun-26 |
| Sell* | 76,391 | 6.54p | Ordinary |
13:27:53 - 23-Jun-26 |
| Sell* | 5,000 | 6.415p | Ordinary |
13:02:52 - 23-Jun-26 |
| Sell* | 5,000 | 6.415p | Ordinary |
12:08:38 - 23-Jun-26 |
| Sell* | 3,000 | 6.415p | Ordinary |
12:02:46 - 23-Jun-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Jun 2026 4:20 pm | RNS | Results of 2026 Annual General Meeting |
| 29th May 2026 9:11 am | RNS | Total Voting Rights |
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
